The Effects Of Nutraceutical, Turmeric And Its Active...
In total, four experiments were conducted to determine the therapeutic and safety effects of the
nutraceutical, turmeric and its active ingredient curcumin on canine and equine. Two studies were
conducted on client owned, moderately arthritic canines, studying the therapeutic and safety effect of
curcumin s anti inflammatory properties. In Exp. 1, two different dosages, 500 mg, SID of 95%
curcumin and 250 mg, BID of 95% liposomal curcumin, were evaluated in ten moderately arthritic
dogs over five months. The dogs in the 95% curcumin group had an overall greater significance in
pain reduction by Day 60. Exp. 2, was a follow up experiment to Exp. 1. In Exp. 2, two different
dosages, 500 mg, SID or 100 mg, SID of 95% curcumin, were evaluated ... Show more content on
Helpwriting.net ...
coli K 12 (P = 0.5114), E. coli general (P = 0.1083), C. difficile (P 0.0001), and C. perfringens (P =
0.2439). The follow up in vitro 24 h batch culture examined four different dosages (15 g, 20 g, 25 g,
and 30 g) of 500 mg/g of LIPC, at reducing the concentration of opportunistic bacteria. These results
were utilized to determine the dosing rate in vivo. Exp. 3, in vivo, evaluated the efficacy of
antimicrobial and anti inflammatory properties of LIPC dosed at 15, 25, and 35 g compared to a
control. These results were utilized to determine the dosing rate in vivo. Exp. 4, in vivo, evaluated the
efficacy of antimicrobial and anti inflammatory properties of LIPC dosed at 15, 25, and 35 g
compared to a control. In vivo, LIPC s antimicrobial properties, at 15 g, significantly decreased (P =
0.02) SBEC compared to other treatments. In addition, C. perfringens tended (P = 0.12) to decrease as
LIPC dose increased. Non significant results in digestion, blood parameters, and range of motion
suggest there were no adverse side effects from oral dosing increasing doses of curcumin. Valerate
was significantly different among treatments (P = 0.02) with 0 having the greatest concentration
compared to all other treatments. Moreover, valerate decreased linearly (P 0.005) as LIPC dose
increased. As LIPC dose
... Get more on HelpWriting.net ...